Xtant Medical Holdings, Inc. (XTNT): Price and Financial Metrics


Xtant Medical Holdings, Inc. (XTNT): $1.15

-0.03 (-2.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

XTNT POWR Grades


  • XTNT scores best on the Growth dimension, with a Growth rank ahead of 94.94% of US stocks.
  • XTNT's strongest trending metric is Momentum; it's been moving down over the last 31 weeks.
  • XTNT's current lowest rank is in the Momentum metric (where it is better than 15.14% of US stocks).

XTNT Stock Summary

  • The price/operating cash flow metric for Xtant Medical Holdings Inc is higher than 92.3% of stocks in our set with a positive cash flow.
  • With a year-over-year growth in debt of -78.1%, Xtant Medical Holdings Inc's debt growth rate surpasses just 3.95% of about US stocks.
  • The volatility of Xtant Medical Holdings Inc's share price is greater than that of 93.59% US stocks with at least 200 days of trading history.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Xtant Medical Holdings Inc are EAST, AIHS, MRC, THG, and FARM.
  • Visit XTNT's SEC page to see the company's official filings. To visit the company's web site, go to www.xtantmedical.com.

XTNT Valuation Summary

  • XTNT's price/earnings ratio is -38.6; this is 205.75% lower than that of the median Healthcare stock.
  • XTNT's price/earnings ratio has moved down 2013.6 over the prior 136 months.
  • XTNT's price/sales ratio has moved down 51.4 over the prior 136 months.

Below are key valuation metrics over time for XTNT.

Stock Date P/S P/B P/E EV/EBIT
XTNT 2021-08-31 2 3.2 -38.6 210.7
XTNT 2021-08-30 2 3.2 -38.3 208.9
XTNT 2021-08-27 2 3.4 -40.2 219.2
XTNT 2021-08-26 2 3.3 -39.3 214.1
XTNT 2021-08-25 2 3.2 -38.3 208.9
XTNT 2021-08-24 2 3.2 -38.3 208.9

XTNT Growth Metrics

  • The 2 year cash and equivalents growth rate now stands at -47.52%.
  • The 3 year net cashflow from operations growth rate now stands at 124.46%.
  • Its 3 year net income to common stockholders growth rate is now at -1782.32%.
Over the past 15 months, XTNT's revenue has gone down $7,186,000.

The table below shows XTNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 55.548 1.787 -2.828
2021-03-31 51.102 -0.249 -4.559
2020-12-31 53.337 -0.731 -7.023
2020-09-30 56.287 -1.718 -7.922
2020-06-30 57.992 -2.943 -8.441
2020-03-31 62.734 -2.692 -7.916

XTNT Stock Price Chart Interactive Chart >

Price chart for XTNT

XTNT Price/Volume Stats

Current price $1.15 52-week high $6.58
Prev. close $1.18 52-week low $0.71
Day low $1.15 Volume 140,983
Day high $1.19 Avg. volume 1,856,459
50-day MA $1.31 Dividend yield N/A
200-day MA $1.71 Market Cap 99.71M

Xtant Medical Holdings, Inc. (XTNT) Company Bio


Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company is based in Montana.


XTNT Latest News Stream


Event/Time News Detail
Loading, please wait...

XTNT Latest Social Stream


Loading social stream, please wait...

View Full XTNT Social Stream

Latest XTNT News From Around the Web

Below are the latest news stories about Xtant Medical Holdings Inc that investors may wish to consider to help them evaluate XTNT as an investment opportunity.

Xtant Medical Announces Second Quarter 2021 Financial Results

BELGRADE, Mont., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the second quarter ended June 30, 2021.

Intrado Digital Media | August 5, 2021

Xtant Medical to Issue Second Quarter 2021 Financial Results on August 5, 2021

BELGRADE, Mont., July 29, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the second quarter ended June 30, 2021, before the open of the financial markets on Thursday, August 5, 2021.

Intrado Digital Media | July 29, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Good morning, traders!

William White on InvestorPlace | July 21, 2021

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Good morning, investor!

William White on InvestorPlace | July 9, 2021

Is XTNT Stock A Buy Here?

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their quarterly 13F filings. The stocks that are heavily bought by hedge funds historically outperformed the market, though there is no shortage of high profile […]

Yahoo | June 19, 2021

Read More 'XTNT' Stories Here

XTNT Price Returns

1-mo -0.86%
3-mo -29.01%
6-mo -61.41%
1-year 33.72%
3-year -73.00%
5-year -91.67%
YTD -3.85%
2020 -25.24%
2019 -0.62%
2018 -76.46%
2017 3.64%
2016 -80.36%

Continue Researching XTNT

Want to see what other sources are saying about Xtant Medical Holdings Inc's financials and stock price? Try the links below:

Xtant Medical Holdings Inc (XTNT) Stock Price | Nasdaq
Xtant Medical Holdings Inc (XTNT) Stock Quote, History and News - Yahoo Finance
Xtant Medical Holdings Inc (XTNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8504 seconds.